Idorsia Ltd (CHF)
IDIA
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range30.84 | 31.64
52-Wk Range- | -
Last Close31.32
Mkt Cap (m)4,456.44
Dividend yield-
ISINCH0363463438
Volume250,269.00
Exchange VenueSWX

Company Profile

Idorsia Ltd is a biopharmaceutical company specialized in the discovery, development and commercialization of molecule therapeutics to treat central nervous system, cardiovascular disorders, immunological disorders and orphan diseases.

Key Information
Price/Earning-
Price/Book76.92
Price/Sales184.44
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -2,025.36
Net Margin %-2,072.33
Return on Equity-117.93
Debt/Equity3.66

Documents

Prospectus
en 26/06/2017
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.idorsia.com

Financials

Income Statement
CHF201420152016201720182019
Revenue (m)--0.00-60.6223.82
Operating Income (m)---322.82--371.08-482.42
Net Income (m)---335.14--386.39-493.61
Basic EPS---2.81--3.10-3.76
Avg. Diluted Shares Outstanding (m)--119.12119.12124.78131.19
Balance Sheet
CHF201420152016201720182019
Current Assets (m)--753.23881.30941.42775.40
Non Current Assets (m)--161.90410.58465.35228.80
Total Assets (m)--915.121,291.881,406.771,004.20
Current Liabilities (m)--65.8893.20104.85110.88
Total Liabilities (m)------
Total Equity (m)--512.31745.44664.68172.44
Cash Flows
CHF201420152016201720182019
Operating Cash Flows (m)---263.3495.50-352.82-462.04
Capital Expenditure (m)---8.68-7.66-14.27-18.99
Figures are quoted in CHF unless stated otherwise
-
No change
31.32
Last Price